BioSpace News Archive

Hoth Therapeutics, Inc. today announced that Robb Knie , Chief Executive Officer, is scheduled to attend the BIO CEO and Investor Conference in New York, NY.

Navega Therapeutics today announced the appointment of Carol Greve-Philips as Chief Business Officer.

Unravel Biosciences, Inc., (“Unravel”), an AI-enabled therapeutics company to advance drugs for complex diseases, today announced the initiation of a clinical program in Colombia, starting with the translation of the widely-used Rett Syndrome Behavioral Questionnaire (RSBQ) into Spanish under an approved human subject research protocol.

ZetrOZ Systems, inventors of sustained acoustic medicine, will display the company’s sam® wearable ultrasound unit at the 2024 annual meeting for the American Academy of Orthopedic Surgeons, February 12-16 in San Francisco.

Heligenics, Inc., introduces a groundbreaking advancement in the discovery of new medicines.

THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, announced that it will enter into a new Collaboration Agreement with Maxx Orthopedics, Inc., a rapidly expanding global orthopedics device company.

Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or the “Company”) today announced the closing of its initial public offering of 1,000,000 shares of common stock at a public offering price of $7.00 per share.

Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced its financial results for the second quarter of fiscal 2024 ended December 31, 2023, and provided an update on recent business developments and outlook.

Sana Biotechnology, Inc. announced that Cell Stem Cell has published a paper titled “Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate.”

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter results on February 27, 2024 at 4:00 PM Eastern Time.